Treatment of heterotopic ossifications secondary to pseudohypoparathyroid.
Pédiatrie, CHU de Limoges, Limoges, France; CHREC, CHU de Limoges, Limoges, France. Electronic address: Vincent.guigonis@chu-limoges.fr.
Vincent
V
Guigonis
Pédiatrie, CHU de Limoges, Limoges, France; CHREC, CHU de Limoges, Limoges, France.
Claire
C
Bahans
Rhumatologie, Lariboisière, AP-HP, Paris, France.
Korng
K
Ea
Dermatologie, Robert-Debré, AP-HP, Paris, France.
Emmanuelle
E
Bourrat
Pédiatrie, CHU de Limoges, Limoges, France; CHREC, CHU de Limoges, Limoges, France.
Anne
A
Lienhardt
Endocrinologie, CHU de Grenoble, Grenoble, France.
Olivier
O
Chabre
Pharmacie, CHU de Limoges, Limoges, France.
Jeremy
J
Jost
Pédiatrie, CHU de Limoges, Limoges, France.
Hadile
H
Mutar
Pharmacie, CHU de Limoges, Limoges, France.
Voa
V
Ratsimbazafy
Endocrinologie pédiatrique, Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
Agnès
A
Linglart
D006801:Humans; D009824:Ointments; D009999:Ossification, Heterotopic / Q000188:drug therapy* / Q000209:etiology*; D011547:Pseudohypoparathyroidism / Q000150:complications*; D013885:Thiosulfates / Q000008:administration & dosage / Q000627:therapeutic use
D009824:Ointments; D013885:Thiosulfates; C017717:sodium thiosulfate
Heterotopic ossifications; Ossifications ectopiques; Pseudohypoparathyroidism; Pseudohypoparathyroïdie; Sodium thiosulfate; Thiosulfate de sodium